Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by wildbird1on Jun 25, 2024 3:01pm
266 Views
Post# 36105569

PDT is the future of cancer treatment.

PDT is the future of cancer treatment.In this link...[url=https://ncbi,nlm.nih.gov/pmc/articles/PMC9913255/][/url]

3. Conclusions
'' As a non-invasive therapy method, PDT has obtained significant progress in recent years....Besides, based on the noninvasive operation and unique therapeutic mechanism,PDT can be perfectly combined with Chemotherapy, Radiotherapy, Immune therapy, and Gene therapy. It is beleived that with continuous optimization of photosensitizer, and PDT-based combined treatment system, PDT has a broader clinical application prospect in cancer treatment''.

IN conclusion..  The non-invasive therapy method, is what make PDT easy to use with other existing treatments. Once TLT-Ruvidar has been approved by the FDA, we could see a flurry of Big Pharma deals, to exploit the non-invasive characteristics of TLT-Ruvidar with other treatments.

TLT has just started to exploit the potential of PDT, the best is yet to come.


<< Previous
Bullboard Posts
Next >>